Wenhua Zheng
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Artemether alleviates Aβ1-42-induced neuronal cell damage via PGC-1α-mediated mitochondrial homeostasis in Alzheimer's disease.
Journal: Cellular signalling
Published: April 28, 2026
Amyloid beta 42 disrupts cardiac function in Alzheimer's disease mice via SLC31A1 upregulation-mediated cuproptosis.
Journal: Basic research in cardiology
Published: December 09, 2025
Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: April 13, 2025
Sigma-1 receptor positive allosteric modulator promotes neuronal survival and improves cognitive deficits in AD mice via sigma-1 receptor/ERK pathway.
Journal: Acta pharmacologica Sinica
Published: February 10, 2025
OTUD1 positively regulates microglia neuroinflammation and promotes the pathogenesis of Alzheimer's disease by deubiquitinating C/EBPβ.
Journal: Acta pharmacologica Sinica
Published: November 11, 2024
Artemisinin alleviates astrocyte overactivation and neuroinflammation by modulating the IRE1/NF-κB signaling pathway in in vitro and in vivo Alzheimer's disease models.
Journal: Free radical biology & medicine
Published: August 28, 2024
TIGAR Suppresses ER Stress-Induced Neuronal Injury through Targeting ATF4 Signaling in Cerebral Ischemia/Reperfusion.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: June 24, 2024
Artemisinin conferred cytoprotection to human retinal pigment epithelial cells exposed to amiodarone-induced oxidative insult by activating the CaMKK2/AMPK/Nrf2 pathway.
Journal: Journal of translational medicine
Published: May 19, 2024
Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1.
Journal: Acta pharmacologica Sinica
Published: February 20, 2024
Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA.
Journal: Biochemical and biophysical research communications
Published: June 13, 2023
Mechanism and Molecular Targets of a Water-Soluble Extract of Artemisia annua on the Treatment of Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Journal: The American journal of Chinese medicine
Published: March 31, 2023
Pharmacological therapies and drug development targeting SARS-CoV-2 infection.
Journal: Cytokine & growth factor reviews
Published: July 27, 2022
Last Updated: 09/26/2026